Unknown

Dataset Information

0

Mesenchymal stem cells-derived exosomes: novel carriers for nanoparticle to combat cancer.


ABSTRACT:

Background

The advancement in novel cancer therapeutics brought a platform combining the properties of exosomes with nanoparticles to precision medicine. The novel therapeutic approach aim is cancer-targeted therapy. Exosomes from mesenchymal stem cells (MSCs-Exo) exhibit unique properties in cancer therapies, which makes them an ideal tool for delivering therapeutic agents into tumor cells. The key role of natural MSCs-Exo is controversial in cancer therapy; however, they can be engineered at their surface or cargo to serve as a smart drug delivery system for cancer-targeted therapy. In the last few years, researchers harnessed nanotechnology to enforce MSCs-Exo for cancer management including, tumor cell tracking, imaging, and tumor cell killing. Different nanoparticles such as gold nanoparticles have particularly been incorporated into MSCs-Exo, which showed an efficient accumulation at the site of tumor with improved anticancer impact. These findings indicate that a hybrid of exosomes-nanoparticles may serve as combination therapy for the effective removal of cancers.

Short conclusion

Although exhibiting impressive potential, the use of nanoparticle-loaded MSCs-Exo as a drug-delivery tool has been troubled by some challenges, therefore, translation to clinic prerequisites further scrutiny. In this review, we focus on nanoparticle-loaded MSCs-Exo as a new cancer therapy and discuss engineered MSC-Exo for target therapy.

SUBMITTER: Abbasi R 

PROVIDER: S-EPMC10709841 | biostudies-literature | 2023 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

Mesenchymal stem cells-derived exosomes: novel carriers for nanoparticle to combat cancer.

Abbasi Reza R   Mesgin Raziye Momen RM   Nazari-Khanamiri Fereshteh F   Abdyazdani Nima N   Imani Zeynab Z   Talatapeh Shabnam Pirnezhad SP   Nourmohammadi Aidin A   Nejati Vahid V   Rezaie Jafar J  

European journal of medical research 20231209 1


<h4>Background</h4>The advancement in novel cancer therapeutics brought a platform combining the properties of exosomes with nanoparticles to precision medicine. The novel therapeutic approach aim is cancer-targeted therapy. Exosomes from mesenchymal stem cells (MSCs-Exo) exhibit unique properties in cancer therapies, which makes them an ideal tool for delivering therapeutic agents into tumor cells. The key role of natural MSCs-Exo is controversial in cancer therapy; however, they can be enginee  ...[more]

Similar Datasets

| S-EPMC8420536 | biostudies-literature
| S-ECPF-GEOD-46950 | biostudies-other
| S-EPMC8143902 | biostudies-literature
| S-EPMC4613597 | biostudies-literature
| S-EPMC5627451 | biostudies-literature
| S-EPMC7004029 | biostudies-literature
| S-EPMC11847882 | biostudies-literature
| S-EPMC6042362 | biostudies-literature
| S-EPMC7473478 | biostudies-literature
| S-EPMC10470003 | biostudies-literature